We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
+7.02%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$192M
AUM Growth
+$3.85M
Cap. Flow
+$130M
Cap. Flow %
67.85%
Top 10 Hldgs %
60.53%
Holding
106
New
35
Increased
12
Reduced
5
Closed
35

Sector Composition

1 Healthcare 62.43%
2 Industrials 9.72%
3 Financials 7.48%
4 Consumer Discretionary 4.71%
5 Technology 2.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
1
CVS Health
CVS
$136B
$22.8M 11.84%
217,000
RRTS
2
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$18.4M 9.57%
28,533
+533
+2% +$341K
CAH icon
3
Cardinal Health
CAH
$53.6B
$15.1M 7.83%
180,000
MCK icon
4
McKesson
MCK
$98.5B
$11.5M 6%
+51,300
New +$11.9M
FOMX
5
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$10.1M 5.25%
984,734
+113,081
+13% +$1.25M
ZVRA icon
6
Zevra Therapeutics
ZVRA
$754M
$10M 5.2%
+34,040
New +$7.42M
PFNX
7
DELISTED
Pfenex Inc.
PFNX
$7.41M 3.85%
381,819
-178,181
-32% -$2.99M
ELV icon
8
Elevance Health
ELV
$80.9B
$7.39M 3.84%
45,000
MFIC icon
9
MidCap Financial Investment
MFIC
$821M
$6.9M 3.59%
325,000
HCA icon
10
HCA Healthcare
HCA
$85.6B
$6.8M 3.54%
75,000
SCI icon
11
Service Corp International
SCI
$11B
$6.47M 3.37%
220,000
SPY icon
12
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$5.7M 2.97%
1,400,000
+350,000
+33% +$73.6M
APO icon
13
Apollo Global Management
APO
$71.1B
$5.54M 2.88%
250,000
MRK icon
14
Merck
MRK
$315B
$3.64M 1.9%
67,072
ALKS icon
15
Alkermes
ALKS
$8.66B
$3.58M 1.86%
55,700
+10,700
+24% +$655K
OPCH icon
16
Option Care Health
OPCH
$3.47B
$3.17M 1.65%
218,467
-81,533
-27% -$1.38M
IVE icon
17
iShares S&P 500 Value ETF
IVE
$48.8B
$2.81M 1.46%
+30,496
New +$2.88M
ACAD icon
18
Acadia Pharmaceuticals
ACAD
$4.39B
$2.72M 1.42%
65,000
IWD icon
19
iShares Russell 1000 Value ETF
IWD
$81.9B
$2.67M 1.39%
+25,920
New +$2.72M
DVAX
20
DELISTED
Dynavax Technologies
DVAX
$2.34M 1.22%
+100,000
New +$2.18M
CMRX
21
DELISTED
Chimerix, Inc.
CMRX
$2.31M 1.2%
50,000
AMGN icon
22
Amgen
AMGN
$201B
$2.3M 1.2%
15,000
PAG icon
23
Penske Automotive Group
PAG
$13.5B
$2.21M 1.15%
+42,500
New +$2.2M
C icon
24
Citigroup
C
$221B
$1.93M 1.01%
35,000
MSFT icon
25
Microsoft
MSFT
$2.98T
$1.84M 0.96%
41,695
+20,734
+99% +$946K

Similar funds

DSC Advisors's Q2 2015 Portfolio in Review

As of Q2 2015, DSC Advisors held 106 positions worth $192M, up 2% from $188M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

DSC Advisors deployed $130M of net new capital in Q2 2015, opening 35 new positions and adding to 12 existing holdings. Its largest new stake was McKesson: 51,300 shares worth $11.5M.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 50% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $3.74M trimmed.

  • DSC Advisors's largest Q2 2015 buy was McKesson: 51,300 shares worth $11.5M.
  • DSC Advisors added most to Foamix Pharmaceuticals Ltd. Ordinary Shares in Q2 2015, an estimated $1.25M increase.
  • DSC Advisors's biggest Q2 2015 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.74M.
  • DSC Advisors fully exited Tapestry in Q2 2015, selling an estimated $6.21M.
  • DSC Advisors's ten largest holdings make up 61% of its $192M portfolio in Q2 2015.
  • DSC Advisors opened 35 new positions and closed 35 in Q2 2015.
  • DSC Advisors's portfolio value rose 2% quarter-over-quarter to $192M.

Based on DSC Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.